{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:14:30Z","timestamp":1762978470216,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3840,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006020","name":"Center for Translational Molecular Medicine","doi-asserted-by":"publisher","award":["01C\u2010102"],"award-info":[{"award-number":["01C\u2010102"]}],"id":[{"id":"10.13039\/501100006020","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1111\/j.1538-7836.2012.04703.x","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T09:57:20Z","timestamp":1332151040000},"page":"1177-1179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Citalopram is a more potent platelet function inhibitor than paroxetine in a case\u2013control study"],"prefix":"10.1016","volume":"10","author":[{"given":"T.C.","family":"VAN HOLTEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"ROEST","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"RIPHAGEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"JANSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"NAARDING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"ADRIAANSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G.","family":"DE GROOT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"REMIJN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(99)00015-8","article-title":"Platelet dense granules: structure, function and implications for haemostasis","volume":"95","author":"McNicol","year":"1999","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.6574604","article-title":"Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets","volume":"221","author":"Cohen","year":"1983","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0020","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/0006-2952(84)90699-3","article-title":"Evidence for functional 5\u2010HT2 receptor sites on human blood platelets","volume":"33","author":"De Clerck","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist\u2010induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth\u2010Evenzal","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.trsl.2007.10.004","article-title":"Selective serotonin reuptake inhibitors: measurement of effect on platelet function","volume":"151","author":"McCloskey","year":"2008","journal-title":"Transl Res"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0040","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2125.2011.04008.x","article-title":"The effect of selective serotonin re\u2010uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression","volume":"72","author":"Kimmel","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","article-title":"Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction","volume":"108","author":"Sauer","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0050","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/hc4101.097519","article-title":"Selective serotonin reuptake inhibitors and myocardial infarction","volume":"104","author":"Sauer","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0055","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2165\/00002018-200427140-00006","article-title":"Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction","volume":"27","author":"Schlienger","year":"2004","journal-title":"Drug Saf"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.0306-5251.2001.01426.x","article-title":"Use of selective serotonin reuptake inhibitors and risk of developing first\u2010time acute myocardial infarction","volume":"52","author":"Meier","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.STR.0000018589.56991.BA","article-title":"Selective serotonin reuptake inhibitors and the risk of stroke: a population\u2010based case\u2010control study","volume":"33","author":"Bak","year":"2002","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","article-title":"Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms","volume":"71","author":"Andrade","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen\u2010induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1160\/TH08-12-0810","article-title":"Serotonergic mechanisms enhance platelet\u2010mediated thrombogenicity","volume":"102","author":"Galan","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/phrs.2001.0817","article-title":"Platelet inhibition by sertraline and N\u2010desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors","volume":"43","author":"Serebruany","year":"2001","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0090","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0002-9149(01)01562-4","article-title":"Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease","volume":"87","author":"Serebruany","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0095","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new\u2010generation antidepressants: a multiple\u2010treatments meta\u2010analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0100","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2011.042663","article-title":"Up\u2010regulation of platelet activation in hemophilia\u00a0A","volume":"96","author":"van Bladel","year":"2011","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH03-05-0330","article-title":"The influence of selective serotonin reuptake inhibitors on human platelet serotonin","volume":"91","author":"Maurer\u2010Spurej","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0110","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.npp.1301355","article-title":"Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose\u2010ranging in\u00a0vitro study","volume":"32","author":"Atar","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1538-7836.2012.04703.x_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1176\/ajp.153.10.1313","article-title":"Exaggerated platelet reactivity in major depression","volume":"153","author":"Musselman","year":"1996","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622062894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04703.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:01:03Z","timestamp":1761534063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622062894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1538783622062894"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04703.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Citalopram is a more potent platelet function inhibitor than paroxetine in a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04703.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}